期刊
VIROLOGY
卷 521, 期 -, 页码 181-189出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.virol.2018.06.009
关键词
RSV; Maternal; Adenovirus; Vaccine
类别
资金
- Taiwan Ministry of Science Technology [MOST 103-2311-B-400-004-MY3]
We evaluated the efficacy of a recombinant adenovirus that expresses a membrane-truncated respiratory syncytial virus (RSV) fusion protein (Ad-F0 Delta TM) in newborns via maternal immunization (MI) of pregnant cotton rats. Intranasal Ad-F0 Delta TM immunization was given to pregnant female rats, and MI-newborn rats were then challenged intranasally with RSV. Anti-RSV IgGs were observed in the serum of MI-newborn rats after birth. The pulmonary viral loads in Ad-F0 Delta TM vs. control vector, Ad-LacZ, and MI-newborns on day 3 post-challenge were reduced by 4 log(10)/g lung. The neutralizing antibody remained for up to 3 weeks in the serum of MI-newborns, which is when weaning began. Ad-F0 Delta TM protected MI-newborns from RSV challenge for 1 week. Vertical transferred protective antibodies were examined in the breast milk and placenta as well. Finally, anti-RSV immunity was not boosted but was only primed during the next RSV exposure in Ad-F0 Delta TM-MI-newborns. Maternal Ad-F0 Delta TM immunization provides acute protection against RSV infection in neonates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据